About syphilis testing
Syphilis is a type of sexually transmitted infections disease caused by the bacteria Treponema pallidum subspecies pallidum. The infection spreads mainly through sexual contact. Congenital syphilis, however, affects infants by transmission of the infection from the infected mother to the fetus. The rate of syphilis infection is high among men and particularly in those men who have sex with men. In 2014, around 36 million people worldwide were infected by syphilis. The global burden of syphilis is gradually increasing. Unprotected sex and sexual intercourse with multiple partners, affected by syphilis infection are the key factors contributing to the spread of this infection. However, early diagnosis of the infection enables quick recovery from the disease. Testing methods employed for syphilis detection includes enzyme immunoassay (EIA) test, venereal disease research laboratory (VDRL) test, rapid plasma reagin (RPR) test, and point of care (POC) test kits.
Technavio's analysts forecast the global syphilis testing market to grow at a CAGR of 4.71% over the period 2014-2019.
Covered in this report
In this report, Technavio covers the present scenario and growth prospects of the global syphilis testing market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of the following product categories:
POC syphilis test
Conventional syphilis test (non-treponemal serology and treponemal serology test)
Technavio's report, Global Syphilis Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, EMEA, and the Americas; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
Americas
APAC
EMEA
Key vendors
Abbott Diagnostic
Alere
Beckman Coulter
Roche Diagnostics
Siemens Healthcare
Other prominent vendors
AccuBioTech
Becton Dickinson and Company
bioLytical Laboratories
Bio-Rad Laboratories
Chembio Diagnostic Systems
Diasorin
DRG International
Grifols
IBL International
MedMira
Omega Diagnostics
Trinity Biotech
ulti med Products
ZEUS Scientific
Key market driver
Increasing prevalence and incidence of syphilis
For a full, detailed list, view our report
Key market challenge
Discrepancies associated with the syphilis test results
For a full, detailed list, view our report
Key market trend
Advances in technology
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be
What are the key market trends
What is driving this market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the key vendors
What are the strengths and weaknesses of the key vendors
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Syphilis test application
PART 07: Market segmentation by technology
POC syphilis test
Conventional syphilis test
Screening approaches to detect syphilis infection
PART 08: Market segmentation by product
Assays/consumables
Instruments
PART 09: Geographical segmentation
Syphilis testing market in Americas
Syphilis testing market in EMEA
Syphilis testing market in APAC
PART 10: Market drivers
Increase in prevalence and incidence of syphilis
Increase in adoption of POC syphilis test
Increase in awareness and government initiatives
PART 11: Impact of drivers
PART 12: Market challenges
Discrepancies associated with syphilis test results
High-cost products
Social stigma associated with syphilis screening
PART 13: Impact of drivers and challenges
PART 14: Market trends
Advances in technology
Focus on rapid and early diagnosis
High growth in emerging countries
PART 15: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 16: Key vendor analysis
Abbott Diagnostics
Alere
Beckman Coulter
Roche Diagnostics
Siemens Healthcare
PART 17: Appendix
List of abbreviation
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global syphilis testing market 2014-2019 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Syphilis testing applications
Exhibit 05: Application and limitations of diagnostic tests in various stages of syphilis
Exhibit 06: Segmentation of global syphilis testing market by technology
Exhibit 07: Segmentation of global syphilis testing market by technology 2014
Exhibit 08: Traditional algorithm method of syphilis screening
Exhibit 09: Reverse algorithm method of syphilis screening
Exhibit 10: Segmentation of global syphilis testing market by product
Exhibit 11: Segmentation of global syphilis testing market by product 2014
Exhibit 12: Segmentation of global syphilis testing market by geography 2014
Exhibit 13: Segmentation of global syphilis testing market by geography 2019
Exhibit 14: Segmentation of global syphilis testing market by geography 2014-2019
Exhibit 15: Syphilis testing market in Americas 2014-2019 ($ millions)
Exhibit 16: Syphilis testing market in EMEA 2014-2019 ($ millions)
Exhibit 17: Distribution of syphilis cases by stage of infection in Europe 2014
Exhibit 18: Percentage of syphilis cases by transmission in Europe 2014
Exhibit 19: Syphilis testing market in APAC 2014-2019 ($ billions)
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: Key takeaways: Abbott Diagnostics
Exhibit 23: Key takeaways: Alere
Exhibit 24: Key takeaways: Beckman Coulter
Exhibit 25: Key takeaways: Roche Diagnostics
Exhibit 26: Key takeaways: Siemens Healthcare
Exhibit 27: Abbott Diagnostics: Key business offerings
Exhibit 28: Alere: Business segmentation by revenue 2014
Exhibit 29: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 30: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
Exhibit 31: Beckman Coulter: Business segmentation
Exhibit 32: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 33: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 34: Roche Diagnostics: Geographical segmentation by revenue 2014
Exhibit 35: Siemens Healthcare: Business segmentation
Exhibit 36: Siemens Healthcare: Geographical segmentation by revenue 2014
